Cardiovascular Risk in Patients With Psoriasis: JACC Review Topic of the Week JACC Targeted Oral Peptide Icotrokinra for Psoriasis Involving High Impact Sites NEJM Evidence Human umbilical cord mesenchymal stem cells for psoriasis: a phase 1 2a, single arm study Signal Transduction and Targeted Therapy Many treatment guidelines for psoriasis rely heavily on body surface area (BSA) involvement to determine disease severity and eligibility for systemic therapies like biologics. Traditionally, patients with less than 10% BSA involvementespecially Frontiers Promising strategies in natural products treatments of psoriasis update Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations JCAD The Journal of Clinical and Aesthetic Dermatology